Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Many nursing homes will not begin inoculations until well into October or even November.
The technology, developed by Katalin Karikó and Drew Weissman, also holds promise for HIV vaccines and cancer treatment.
Biden’s CUREIT initiative aims to develop a toolbox of technologies to fight cancer, autoimmune disorders and infectious diseases.
Researchers are working on vaccines that will target multiple flu or coronavirus strains.
The experimental vaccine regimen trains the immune system to produce broadly neutralizing antibodies that target HIV.
Experimental flu vaccine, designed to elicit immunity against a broad range of influenza viruses, performed well in a small trial.
Researchers are exploring novel strategies to help the immune system produce broadly neutralizing antibodies.
Overall, people with and without HIV had low and comparable rates of severe breakthrough illness.
This year’s most widely viewed science news focused on HIV cure research, monkeypox and PEP for sexually transmitted infections.
Experimental vaccine aims to train B cells to produce broadly neutralizing antibodies that target HIV.
Novel therapies, improved technologies and a better understanding of the immune system could yield broad dividends.
HIV mutates rapidly, enabling the virus to evade the common, narrowly targeted antibodies produced by most people with HIV.
The experimental vaccine regimen aims to train B cells to produce broadly neutralizing antibodies against HIV.
A study of HIV vaccines that use the same messenger RNA (mRNA) approach as highly effective COVID-19 vaccines has been launched.
The experimental vaccines use the same technology as the highly effective Moderna COVID-19 shot.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.